Teaching and Learning Slide Sets

Physician Education

Heart Failure
Author: Nurcan Ilksoy, MD, Assistant Professor of Medicine, Emory University School of Medicine
Description: Basic epidemiology & pathophysiology of Heart Failure, diagnosis, evaluation, keys of management and discharge planning

View the Heart Failure Slide Set.

New Issues in the Management of Congestive Heart Failure
This slide set is from the lecture presented at the Society of Hospital Medicine’s 2004 Annual Meeting by Franklin A. Michota, MD, Assistant Professor of Medicine Medical Director, Center for Post-Acute Medicine Head, Section of Hospital Medicine, The Cleveland Clinic Foundation

Heart Failure Practice Guideline Key Recommendation Slide Set
This slide set can be found via the Heart Failure Society of America website.  It is based on the HFSA 2006 Guideline (JCF 2006;6:1e-199e) and was developed as a resource to speakers.

View the Heart Failure Practice Guideline Key Recommendation Slide Set

Learn more about the HFSA Comprehensive Heart Failure Practice Guideline

Prevention of Sudden Cardiac Death in Heart Failure Patients with Left Ventricular Dysfunction:
The Role of Drugs and Devices
This slide set is from www.Medtronic.com authored by: William T. Abraham, MD, FACP, FACC Professor of Medicine Chief, Division of Cardiovascular Medicine Associate Director, Davis Heart & Lung Research Institute, The Ohio State University Columbus, Ohio.
The objectives of the slide set are to review the scientific evidence to support the contentions that:

•  In patients with LV dysfunction, the combined use of ACE inhibition and beta-blockade is recommended as the cornerstone of therapy.
• Modest incremental benefit may be seen with the addition of other antagonists of the RAS in post-MI LV dysfunction and in chronic heart failure.
• While neurohormonal interventions reduce morbidity and mortality across the cardiovascular disease continuum, post-MI and HF patients with LV dysfunction still have a high rate of sudden cardiac death.
• Therapy with ICDs significantly reduces mortality in post-MI patients with LV dysfunction. These mortality benefits are on top of optimal pharmacologic therapy. ICD therapy should be considered standard of care in these patients.
• Data from SCD-HeFT will be critical to understand the role of ICD therapy in ischemic and non-ischemic CHF patients with LV dysfunction.

View the Prevention of Sudden Cardiac Death in Heart Failure Patients slide set

*Please note: Due to the large file size of these slide sets, extended download times may be experienced on some computers.

Nursing Education

View the Dyspnea and Heart Failure Case Study.